Bio-Techne Corp/ US09073M1045 /
2024-03-28 5:51:39 PM | Chg. +0.79 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
70.21USD | +1.14% | 18,267 Turnover: 1.28 mill. |
-Bid Size: - | -Ask Size: - | 2.71 bill.USD | 1.85% | 9.98 |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 6.93 USD | 91.44% |
EPS Diluted: | 6.63 USD | 91.07% |
Revenues per Share: | 28.19 USD | 17.32% |
Book Value per Share: | 43.37 USD | 6.96% |
Cash Flow per Share: | 8.29 USD | -8.75% |
Dividend per Share: | 1.28 USD | 0.00% |
Total | in mill. | |
Revenues: | 1,105.60 USD | 18.75% |
Net Income: | 272.10 USD | 93.80% |
Operating Cash Flow: | 325.30 USD | - |
Cash and Cash Equivalents: | 172.60 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 9.98 | 74.65 |
P/S Ratio: | 2.45 | 18.35 |
P/BV ratio: | 1.60 | 11.93 |
P/CF Ratio: | 8.34 | 62.37 |
PEG: | 0.11 | 0.82 |
Earnings Yield: | 10.02% | 1.34% |
Dividend Yield: | 1.85% | 0.25% |
Market Capitalization | ||
Market Capitalization: | 2.71 bill. USD | 20.29 bill. USD |
Free Float Market Cap.: | 2.15 bill. USD | 16.11 bill. USD |
Market Cap. / Employee: | 904,526.0992 USD | 6.76 mill. USD |
Shares Outstanding: | 39.22 mill. |
Profitability
Gross Profit Margin: | 68.42% |
EBIT Margin: | 26.83% |
Net Profit Margin: | 24.61% |
Return on Equity: | 16.00% |
Return on Assets: | 11.86% |
Financial Strength
Liquidity I / Cash Ratio: | 98.07% |
Liquidity II / Quick Ratio: | 208.58% |
Liquidity III / Current Ratio: | 344.09% |
Debt / Equity Ratio: | 34.91% |
Dynam. Debt / Equity Ratio: | 182.54% |
Efficiency
Employees: | 3,000 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 368,533.33 USD |
Net Income / Employee: | 90,700.00 USD |
Total Assets / Employee: | 764,933.33 USD |
* Fiscal Year End: | 2022-06-30 |
Accounting Standard: | US GAAP |
Currency: | USD |